← All organizations

The Beijing Pregene Science and Technology Company, Ltd.

For profitWebsite ↗

Also known as: The Pregene (ShenZhen) Biotechnology Company, Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 22, 2018

Defunct as of Dec 31, 2020

Timeline

2010s

Jun 1, 2014
The Beijing Pregene Science and Technology Company, Ltd.— Founded

2020s

Dec 31, 2020
The Beijing Pregene Science and Technology Company, Ltd.— Defunct

Drugs by trial phase (6 distinct, 10 trials)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

car19 t cells carrying cytoplasmic activated pd-1

Indications

Studied for

Recent trials (10)

NCT03542799CollaboratorPhase 1May 22, 2018
NCT03540303CollaboratorPhase 1Apr 12, 2018
NCT03664661CollaboratorPhase 1Apr 11, 2018
NCT03661554Lead sponsorEarly Phase 1Apr 10, 2018
NCT03322735CollaboratorPhase 1/Phase 2Dec 8, 2017
NCT03263208CollaboratorPhase 1/Phase 2Aug 16, 2017
NCT03152435CollaboratorPhase 1/Phase 2Jun 1, 2017
NCT03146533CollaboratorPhase 1/Phase 2May 1, 2017
NCT02924753CollaboratorPhase 1Sep 1, 2016
NCT03101709CollaboratorPhase 1Aug 1, 2016

Details

Founded: Beijing, CN Jun 1, 2014
Last known activity: May 22, 2018